# FinRobot earnings analysis on GEV

_P4_earnings — FinRobot pipeline `earnings`, generated 2026-09-30 00:11:34_


## Earnings Data

Beat rate: 0%. Avg EPS surprise: +0.0%. Avg revenue surprise: +0.0%. Consecutive beats: 0. Quarters analyzed: 0.


## Financial Context

# GE Vernova Inc. (GEV): Financial Context Data Summary

**Scope:** This summary covers only the data included in the step prompt. I made no new tool calls, so nothing here was freshly retrieved.

**Source (as stated in the supplied data):** provider `yfinance`, `from_cache: true`
**Timestamp (as stated):** as_of / fetched_at `2026-09-30T04:04:38.734228Z`
**Period labeling:** The file says `period_basis: "ttm"`, but the provider's `degraded` field says **"period_basis_unknown"**. `period_end` is null and `ttm_quarter_ends` is empty. Every flow figure below is therefore labeled **"TTM (stated) / period unknown"**.

---

## 1. Company Identification

| Field | Value |
|---|---|
| Ticker | GEV |
| Company | GE Vernova Inc. |
| Sector / Industry | Industrials / Specialty Industrial Machinery |
| Country | United States |
| ADR status | null (not provided) |
| Reporting currency | USD |
| Quote currency | USD |

---

## 2. Income Statement (USD; TTM stated / period unknown)

| Metric | Value | Notes |
|---|---|---|
| Revenue | USD 41.37 B | TTM stated / period unknown |
| EBITDA | USD 3.93 B | TTM stated / period unknown |
| Net Income | USD 9.53 B | TTM stated / period unknown; **suspicious** (see §8) |
| Gross Margin | 20.57 % | TTM stated / period unknown |
| Operating Margin | 7.466 % | TTM stated / period unknown |
| Operating Income | not provided | null |
| Income Tax Expense | not provided | null |
| D&A | not provided | null |
| R&D Expense | not provided | null |
| SG&A Expense | not provided | null |
| Interest Expense | not provided | null |

---

## 3. Cash Flow (USD; TTM stated / period unknown)

| Metric | Value | Notes |
|---|---|---|
| Operating Cash Flow | USD 14.14 B | TTM stated / period unknown |
| Capital Expenditure | USD −1.58 B | TTM stated / period unknown |
| *FCF (derived: OCF + CapEx)* | *USD 12.56 B* | *My arithmetic, not provider-reported* |

---

## 4. Balance Sheet (USD; point-in-time, date unknown)

| Metric | Value | Notes |
|---|---|---|
| Total Debt | USD 3.72 B | |
| Total Cash | USD 12.72 B | |
| *Net Cash (derived: Cash − Debt)* | *USD 9.00 B* | *Derived* |
| Book Value per Share | USD 44.895 | |
| *Implied Book Equity (derived: BVPS × shares)* | *≈ USD 11.96 B* | *Derived* |
| Preferred Stock | not provided | null |
| Noncontrolling Interest | not provided | null |

---

## 5. Market Data & Valuation (USD)

| Metric | Value | Notes |
|---|---|---|
| Current Price | **not provided** | null |
| *Implied Price (derived: Market Cap ÷ Shares)* | *≈ USD 962.47* | *Derived. Matches P/E × trailing EPS (≈ USD 962.5)* |
| Market Capitalization | USD 256.34 B | |
| Shares Outstanding | 266.33 M | |
| P/E (trailing) | 27.25x | `pe_ttm_lag_quarters` null |
| Forward P/E | 38.31x | |
| Trailing EPS | USD 35.32 | TTM stated / period unknown |
| Forward EPS | USD 25.13 | Forward period not specified |
| *Enterprise Value (derived: Mkt Cap + Debt − Cash)* | *≈ USD 247.34 B* | *Derived; excludes preferred stock and NCI (both null)* |
| *EV / EBITDA (derived)* | *≈ 63.0x* | *Derived; EBITDA is TTM stated / period unknown* |
| *EV / Revenue (derived)* | *≈ 5.98x* | *Derived* |
| Beta | not provided | null |

---

## 6. Returns & Shareholder Distributions

| Metric | Value | Notes |
|---|---|---|
| Return on Equity | 82.58 % | Provider-reported; see §8 |
| Dividend per Share | USD 2.00 | Period basis not specified (likely annual) |
| Dividend Yield | 0.21 (raw) | **Unit ambiguous.** Probably 0.21 %, since USD 2.00 ÷ ~USD 962 ≈ 0.21 %. Not 21 % |
| Payout Ratio | 5.73 % | Cross-check: USD 2.00 ÷ USD 35.32 ≈ 5.66 % |

---

## 7. Earnings Surprise History (from earnings_data step)

| Metric | Value |
|---|---|
| Surprise records | **0 (empty array)** |
| Beat rate | 0.0 |
| Avg EPS surprise % | 0.0 |
| Avg revenue surprise % | 0.0 |
| Consecutive beats | 0 |

**Note:** These zeros come from an empty dataset. They are placeholders and do not mean the company recorded 0 beats. Treat earnings surprise history as **missing**.

---

## 8. Data Quality Warnings

1. **Period basis conflict: "period_basis_unknown".** The file says TTM, but the provider flags `period_basis_unknown`. In addition, `period_end` is null and `ttm_quarter_ends` is empty. All flow figures (revenue, EBITDA, net income, OCF, CapEx, EPS) should be treated as **period unknown**.
2. **Cached, possibly stale.** `from_cache: true`. The as_of and fetched_at timestamps are identical, so the actual date of the underlying data can't be confirmed.
3. **Suspicious: net income is larger than EBITDA.** Net income is USD 9.53 B and EBITDA is USD 3.93 B, about 2.4x. That would give a net margin of about 23.0 % against an operating margin of about 7.5 %. This is unusual. It could reflect non-operating or one-time items, or a mismatch between periods. I could not check which, because no breakdown is provided.
4. **Suspicious: forward EPS well below trailing EPS.** Forward EPS is USD 25.13 and trailing is USD 35.32. This fits trailing EPS being inflated by the same item as in #3, but that can't be confirmed.
5. **Suspicious: high ROE.** ROE of 82.58 % is driven by the net income figure in #3. The derived check (NI ÷ implied equity ≈ 79.7 %) roughly agrees.
6. **Operating cash flow is large relative to revenue.** OCF of USD 14.14 B is about 34 % of revenue, well above both operating margin and the EBITDA margin (≈ 9.5 %). Flagged for checking.
7. **Current price missing.** The implied price (≈ USD 962.47) is derived only. Market cap, P/E, and forward P/E agree with each other.
8. **Dividend yield unit is ambiguous.** The raw value is 0.21. Read it as a percentage (≈ 0.21 %), not a decimal fraction.
9. **Missing fields:** operating income, income tax expense, D&A, R&D, SG&A, interest expense, preferred stock, NCI, beta, period end, and ADR status.
10. **Earnings surprise data is empty.** Values in §7 are defaults, not observations.
11. **Derived figures are mine, not the provider's.** FCF, net cash, EV, EV/EBITDA, EV/Revenue, implied price, and implied equity are my own arithmetic on the supplied fields. They are marked in *italics*.


## Earnings Analysis

# GE Vernova Inc. (GEV): Earnings Analysis

## 1. Executive Summary

| Item | Assessment |
|---|---|
| Earnings surprise track record | **Cannot be assessed.** The surprise dataset is empty (0 quarters). The reported 0% beat rate and +0.0% average surprises are defaults, not observations. |
| Headline trailing earnings quality | **Low confidence.** Net income of USD 9.53 B (TTM stated / period unknown) is about 2.42x EBITDA of USD 3.93 B (same basis). Core operations cannot produce that result, so trailing EPS almost certainly includes large non-operating or one-time items. |
| Trailing-to-forward EPS path | Consensus-style forward EPS of USD 25.13 (forward period unspecified) is **−28.9%** below trailing EPS of USD 35.32 (TTM stated). This fits a non-recurring item dropping out of trailing earnings. |
| Cash earnings | FCF of USD 12.56 B (derived, TTM stated) is about 1.32x net income and about 3.2x EBITDA. Cash conversion is unusually strong, but it probably includes working-capital or customer-advance effects. It should not be treated as run-rate. |
| Most reliable earnings anchor | **Forward EPS (USD 25.13)** and **operating income (≈ USD 3.09 B, derived, TTM stated)**. Trailing P/E of 27.25x (TTM) should not be relied on. |

**Bottom line:** No surprise momentum can be established from this data. The trailing P/E of 27.25x (TTM) looks cheaper than the market actually prices GEV's core earnings. On forward and operating bases the stock sits at a much higher multiple (see §6).

---

## 2. Data Availability and Limitations

| Input | Status | Impact on analysis |
|---|---|---|
| Quarterly EPS actual vs. estimate | Missing (empty array) | No beat/miss rate, surprise magnitude, or streak analysis is possible. |
| Quarterly revenue actual vs. estimate | Missing | Top-line execution vs. expectations is unknown. |
| Guidance history | Not provided | Guide-raise/cut behavior cannot be evaluated. |
| Period end / TTM quarter ends | Null / empty; provider flags `period_basis_unknown` | Every flow figure is labeled "TTM stated / period unknown". Cross-metric ratios assume the same period, which is unverified. |
| Operating income, D&A, tax, interest | Null | Operating income and D&A are back-solved from margins (see §4). The below-EBITDA bridge to net income cannot be built. |
| Data freshness | `from_cache: true` | May be stale relative to the 2026-09-30 timestamp. |

---

## 3. Earnings Surprise Analysis

**Result: not computable.**

| Metric | Reported value | Interpretation |
|---|---|---|
| Quarters analyzed | 0 | No sample |
| Beat rate | 0.0% | Placeholder. It does **not** mean GEV missed every quarter. |
| Avg EPS surprise | +0.0% | Placeholder |
| Avg revenue surprise | +0.0% | Placeholder |
| Consecutive beats | 0 | Placeholder |

**Required to complete this section (next data pull):**
1. Last 8 quarters of EPS actual vs. consensus, with the GAAP vs. adjusted basis stated.
2. Last 8 quarters of revenue actual vs. consensus.
3. Orders and backlog vs. expectations. For a long-cycle equipment supplier, these often move the stock more than the EPS print does.
4. Full-year guidance changes at each print.
5. Stock reaction on each earnings date, to test whether beats were already priced in.

Downstream steps should apply **no earnings-momentum premium or discount** to GEV until this data is available.

---

## 4. Earnings Quality Decomposition (TTM stated / period unknown)

| Line | Value | Margin on Revenue (USD 41.37 B) | Source |
|---|---|---|---|
| Revenue | USD 41.37 B | 100.0% | Provider |
| Gross profit | ≈ USD 8.51 B | 20.57% | Derived from provider gross margin |
| Operating income | ≈ USD 3.09 B | 7.47% | Derived: 7.466% × USD 41.37 B |
| EBITDA | USD 3.93 B | 9.50% | Provider / derived margin |
| Implied D&A | ≈ USD 0.84 B | ≈ 2.0% | Derived: EBITDA − operating income. Valid only if both are for the same period. |
| **Net income** | **USD 9.53 B** | **23.04%** | Provider |
| **Net income − operating income** | **≈ USD 6.44 B** | ≈ 15.6% | Derived |

**Key observation:** Net income exceeds operating income by about USD 6.44 B (derived, TTM stated). That figure is a **lower bound** on non-operating contribution. It already assumes zero tax and zero interest cost; any positive tax charge would make the non-operating contribution larger.

Possible explanations, none verifiable without a below-the-line breakdown:
- A gain on sale or revaluation of an investment or business.
- A tax benefit, such as a valuation-allowance release or deferred tax asset recognition.
- Discontinued operations or other one-time items.
- A period mismatch between net income and EBITDA/margins, given the `period_basis_unknown` flag.

**Cross-check on internal consistency:**
- Trailing EPS USD 35.32 × 266.33 M shares ≈ USD 9.41 B. This is within about 1.3% of reported net income of USD 9.53 B, so EPS and net income agree with each other. The anomaly is in the NI vs. EBITDA relationship, not in EPS arithmetic.
- ROE of 82.58% (provider) and NI ÷ implied equity of ≈ 79.7% (derived; USD 9.53 B ÷ ≈ USD 11.96 B) are both inflated by the same item. **Neither should be used as a sustainable return metric.**

---

## 5. Trailing-to-Forward EPS Bridge

| Metric | Value | Basis |
|---|---|---|
| Trailing EPS | USD 35.32 | TTM stated / period unknown |
| Forward EPS | USD 25.13 | Forward period unspecified (assume FY1/NTM) |
| Change | **−28.9%** | Derived |
| Implied forward net income | ≈ USD 6.69 B | Derived: USD 25.13 × 266.33 M shares |
| Implied forward net margin on TTM revenue | ≈ 16.2% | Derived. Illustrative only, since forward revenue is not provided. |

**Interpretation:**
- The EPS decline most likely reflects the trailing one-time item rolling off. It is **not** a sign that the operations are deteriorating.
- Even the forward figure is striking. Implied forward net income of ≈ USD 6.69 B is about 2.2x trailing operating income of ≈ USD 3.09 B (TTM stated). Two explanations fit:
  - (a) Consensus expects substantial revenue growth and margin expansion.
  - (b) Forward estimates also carry non-operating items.

  Without forward revenue and EBITDA estimates, the two cannot be separated. This is the **single most important open question**


## Forward Outlook

# GE Vernova Inc. (GEV): Forward Outlook

## 1. Summary

| Item | Assessment |
|---|---|
| **Directional recommendation** | **HOLD**, with downside skew on valuation |
| **Price target** | **Withheld (null).** No DCF or comps valuation was computed upstream, so there is nothing to cross-check. I will not invent a point estimate from multiples alone. |
| **What the market is pricing** | About **63.0x EV/EBITDA** (derived; TTM stated / period unknown), about **80x EV/operating income** (derived), and **38.31x forward P/E**. These multiples price in a multi-year surge in core earnings. |
| **What the market may be mispricing** | The **trailing P/E of 27.25x (TTM) is cosmetically cheap**. It rests on net income of USD 9.53 B, which is about 2.42x EBITDA and inflated by an unexplained item of about USD 6.44 B or more (derived). On core earnings, GEV is one of the most richly priced names in Industrials. |
| **Largest uncertainty** | Whether the USD 25.13 forward EPS (period unspecified) reflects real operating growth or still includes non-operating items. |
| **Confidence** | **Low to moderate.** The period basis is unknown, the data comes from cache, and the surprise history, guidance, orders and backlog are all missing. |

**Why HOLD rather than BUY or SELL:**
- The reverse-valuation arithmetic in §3 shows the current price already requires roughly **16–20% annual EBITDA growth for five years just to earn a zero return**, under illustrative terminal multiples. That argues against BUY.
- The balance sheet (net cash of USD 9.00 B, derived) and cash generation (FCF of USD 12.56 B, derived, TTM stated) are strong.
- There is no forward revenue, orders or backlog data to show the bar cannot be cleared.

A SELL would need evidence that forward operating growth falls short of the implied path. That evidence is not in the dataset.

---

## 2. Forward Earnings Baseline

| Metric | Value | Basis | Reliability |
|---|---|---|---|
| Forward EPS | USD 25.13 | Forward period unspecified (assumed FY1/NTM) | Moderate |
| Implied forward net income | ≈ USD 6.69 B | Derived: USD 25.13 × 266.33 M shares | Moderate |
| Trailing EPS | USD 35.32 | TTM stated / period unknown | **Low**, inflated by a one-time item |
| Trailing → forward EPS change | −28.9% | Derived | Most likely the one-time item rolling off |
| Trailing operating income | ≈ USD 3.09 B | Derived: 7.466% × USD 41.37 B, TTM stated | Moderate |
| Trailing EBITDA | USD 3.93 B | TTM stated / period unknown | Moderate |
| Forward NI ÷ trailing operating income | ≈ 2.2x | Derived | Central open question |

**Interpretation.** The clean forward anchor is USD 25.13 EPS. Delivering about USD 6.69 B of net income from a business now earning about USD 3.09 B of operating income requires one of two things:
- **(a) Rapid operating growth.** This means revenue growth plus margin expansion from a 7.47% operating margin and a 20.57% gross margin (TTM stated).
- **(b) Continued non-operating contributions** in the forward estimates.

Scenario (a) supports the valuation. Scenario (b) means the 38.31x forward P/E understates how expensive the core business is.

---

## 3. Market-Implied Expectations (Reverse Valuation, Illustrative)

No DCF was computed upstream. The arithmetic below uses the supplied EV of **≈ USD 247.34 B (derived)** to show what the current price assumes. **The terminal multiples and the hurdle rate are my illustrative assumptions, not upstream outputs.** They define the size of the bar, not a target.

### 3a. EBITDA required in Year 5 (from TTM EBITDA of USD 3.93 B)

| Scenario | Terminal EV/EBITDA (assumed) | Year-5 EV required | Year-5 EBITDA required | Implied EBITDA CAGR |
|---|---|---|---|---|
| Zero return, EV held flat | 30x | USD 247.3 B | ≈ USD 8.24 B | **≈ 16.0%** |
| Zero return, EV held flat | 25x | USD 247.3 B | ≈ USD 9.89 B | **≈ 20.3%** |
| ~8% annual return (assumed hurdle) | 30x | ≈ USD 363.4 B | ≈ USD 12.11 B | **≈ 25.2%** |
| ~8% annual return (assumed hurdle) | 25x | ≈ USD 363.4 B | ≈ USD 14.54 B | **≈ 29.9%** |

### 3b. Revenue path implied by the zero-return / 25x case (EBITDA of ≈ USD 9.89 B)

| Year-5 EBITDA margin (assumed) | Revenue required | Implied revenue CAGR from USD 41.37 B |
|---|---|---|
| 9.5% (TTM stated, unchanged) | ≈ USD 104 B | ≈ 20% |
| 15% | ≈ USD 65.9 B | ≈ 9.8% |
| 20% | ≈ USD 49.4 B | ≈ 3.6% |

### 3c. Forward P/E de-rating test

For the P/E to compress from 38.31x to an assumed 25x within three years while the price stays at about USD 962.47 (derived), EPS must reach about USD 38.50. That requires **≈ 15.3% EPS CAGR** from USD 25.13.

**Takeaway.** The market is effectively betting on **major margin expansion**, roughly a doubling of the EBITDA margin from 9.5%, on top of healthy revenue growth. If margins do expand to 15–20%, the implied revenue growth is only moderate. If margins stay near current levels, the implied revenue growth is very demanding. Without forward revenue, orders or backlog data, I cannot say which
